IL17A and liver cancer: The study identified flavonoids such as wogonin, Rhamnazin, quercetin, baicalein, and luteolin, which may act on targets such as CDK1, CDK4, SRC, and E2F1 through pathways including PI3K-Akt signaling, IL-17 signaling, and TNF signaling, thereby inhibiting the proliferation of liver cancer cells [9].